Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis

BACKGROUND: Opioid-induced constipation (OIC) is one of the most common adverse events of opioid therapy and can severely reduce quality of life (QOL). Naldemedine is the orally available peripheral-acting μ-opioid receptor antagonist approved for OIC treatment. However in daily clinical practice, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanbayashi, Yuko, Shimizu, Mayumi, Ishizuka, Yuichi, Sawa, Shohei, Yabe, Katsushige, Uchida, Mayako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733844/
https://www.ncbi.nlm.nih.gov/pubmed/36490241
http://dx.doi.org/10.1371/journal.pone.0278823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733844/
https://www.ncbi.nlm.nih.gov/pubmed/36490241
http://dx.doi.org/10.1371/journal.pone.0278823

Ejemplares similares